QFT-Plus leads the industry with innovative CD8 technology

 

During M. tuberculosis infection, CD4 T cells play a critical role in immunological control through their secretion of the cytokine IFN-γ (Figure 1). Evidence now also supports a role for CD8 T cells in host defense against M. tuberculosis. CD8 T cells produce IFN-γ and other soluble factors to (1–3):

  • Suppress M. tuberculosis growth
  • Kill infected cells
  • Directly lyse intracellular Mycobacteria

 

Moreover, research indicates that TB-specific CD8 T cells that produce IFN-γ have been:

  • More frequently detected in those with active TB disease vs. latent infection (4, 5)
  • Associated with recent exposure to TB (6)
  • Detectable in active TB subjects with HIV co-infection and young children (7–9)
QFT-Plus IGRA technology.

Figure 1. QFT-Plus IGRA technology. APC, antigen-presenting cell; MHC, major histocompatibility complex.

Learn more about the technology behind QFT-Plus

Watch Dr. Jeff Boyle, Senior Director of Infection and Immune Diagnostics at QIAGEN, as he describes the development of QFT-Plus and introduces the research support and potential benefits of QFT-Plus CD8 T cell technology. This webinar was recorded in November, 2017.

 

This video is for informational purposes only. For comprehensive instructions for use, consult the QuantiFERON-TB Gold Plus Package Insert, which can be downloaded by visiting the QFT-Plus Package Inserts page.

Potential for additional clinical insights

Research studies indicate the potential for additional clinical information based upon the CD8 T cell response to TB infection. For more information, download our research studies flyer below:

References

1. Turner, J. et al. (1996) Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 87, 339.
2. Brookes, R.H. et al. (2003) CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human microphages. Eur. J. Immunol. 33, 3293.
3. Stenger, S. et al. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121.
4. Day, C.L. et al. (2011) Functional capacity of Mycobacterium tuberculosis specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187, 2222.
5. Rozot, V. et al. (2013) Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur. J. Immunol. 43, 1568.
6. Nikolova, M. et al. (2013) Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn. Microbiol. Infect. Dis. 75, 277.
7. Chicchio, T. et al. (2014) Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J. Infect. 69, 533.
8. Ongaya, A. et al. (2013) Mycobacterium tuberculosis-specific CD8+ T cell recall in convalescing TB subjects with HIV co-infection. Tuberculosis 93, S60.
9. Lanicioni, C. et al. (2012) CD8+ T cells provide an immunologic signature of tuberculosis in young children. Am. J. Respir. Crit. Care Med. 185, 206.

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

Get in touch with QIAGEN
Follow QIAGEN on: